US01625V1044
US01625V1044
Alignment Healthcare, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.57B EUR | 4.93B EUR | 3.64B EUR | 4.03B EUR |
Enterprise Value | 1.44B EUR | 4.57B EUR | 3.27B EUR | 3.79B EUR |
Valuation Multiples | ||||
Trailing P/E | 39.71x | 121.2x | 183.86x | 480.58x |
Forward P/E | 10.27x | -- | -- | -- |
Price to Sales | 0.34x | 1.08x | 0.86x | 1.33x |
Price to Book | 5.89x | 18.61x | 17.6x | 22.49x |
EV/Revenue | 0.31x | 1x | 0.77x | 1.25x |
EV/EBITDA | 16.42x | 52.81x | 49.15x | 87.88x |
Price to FCF (P/FCF) | 8.3x | 27.79x | 16.11x | 38.48x |
EV/FCF | 7.61x | 25.74x | 14.44x | 36.13x |
FCF Yield | 12.05% | 3.6% | 6.21% | 2.6% |